Welcome to LookChem.com Sign In|Join Free
  • or
N-[1-AMINO-6-METHYL-2-OXO-5-(1H-PYRAZOL-5-YL)-1,2-DIHYDRO-3-PYRIDINYL]-4-CHLOROBENZENECARBOXAMIDE is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

321385-49-3

Post Buying Request

321385-49-3 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

321385-49-3 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 321385-49-3 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 3,2,1,3,8 and 5 respectively; the second part has 2 digits, 4 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 321385-49:
(8*3)+(7*2)+(6*1)+(5*3)+(4*8)+(3*5)+(2*4)+(1*9)=123
123 % 10 = 3
So 321385-49-3 is a valid CAS Registry Number.

321385-49-3SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 18, 2017

Revision Date: Aug 18, 2017

1.Identification

1.1 GHS Product identifier

Product name N-[1-Amino-6-methyl-2-oxo-5-(2H-pyrazol-3-yl)-1,2-dihydro-pyridin-3-yl]-4-chloro-benzamide

1.2 Other means of identification

Product number -
Other names -

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:321385-49-3 SDS

321385-49-3Upstream product

321385-49-3Downstream Products

321385-49-3Relevant academic research and scientific papers

Methods for treatment of cancer or neoplastic disease and for inhibiting growth of cancer cells and neoplastic cells

-

, (2008/06/13)

The present invention provides methods for treating or preventing cancer or neoplastic disease comprising administering to a patient a compound having the features of a pharmacophore for human anti-apotptotic Bcl protein inhibitors or identified by the in vitro methods for identifying anti-apotptotic-Bcl protein inhibitors. Also disclosed are methods for inhibiting the growth of a cancer cell or a neoplastic cell, comprising contacting the cancer cell or neoplastic cell with a compound having the features of a pharmacophore for human anti-apoptotic-Bcl protein inhibitors.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 321385-49-3